ReviewResearch and practice in thrombosis and haemostasis2026
Capturing the late complications of venous thromboembolism.
Review in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A state-of-the-art lecture titled "Capturing the late complications of venous thromboembolism: the role of patient-reported outcomes" was presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress 2025 in Washington, DC. Venous thromboembolism (VTE) is increasingly recognized as a chronic condition with substantial long-term complications that extend beyond recurrence, bleeding, and survival. Many patients with VTE experience persistent pain, dyspnea, fatigue, anxiety, and reduced quality of life. Frequently used terms for clinical sequalae include postthrombotic syndrome and postpulmonary embolism syndrome, the latter of which includes chronic thromboembolic pulmonary hypertension. Despite the impact of these long-term complications, they are rarely addressed systematically in routine daily practice. Patient-reported outcome measures provide a structured framework for capturing these late complications, complementing clinical outcomes and offering unique insights into the patient perspective. This review outlines why late complications should be systematically captured, describes the patient-reported outcome measures commonly used to assess them, and discusses key opportunities and challenges for their integration into clinical practice. Finally, we summarize relevant new data on this topic presented during the 2025 ISTH Congress.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.